What You Should Know:
- Glytec, a provider of an AI-powered technology platform for diabetes and related conditions, secures a $36M growth investment led by Savitr Capital and Hayfin Capital Management.
- The funding will fuel the continued expansion of Glytec’s platform, including its flagship Glucommander® SaaS solution, and accelerate the development of innovative new technologies. The investment comes as healthcare systems face increasing pressure to improve inpatient
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Artera Launches Real-World Registry to Track AI’s Impact in Cancer Care
What You Should Know:
- Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced the launch of its DIRECT-AI registry study. This new study will assess how the ArteraAI Prostate Test influences treatment decision-making between clinicians and patients with localized prostate cancer.
- The study will also monitor participants to evaluate their long-term cancer outcomes, reinforcing Artera's commitment to advancing
Read More
Omada Health Data Shows Companion Program Significantly Boosts GLP-1 Medication Persistence
What You Should Know:
- Omada Health, the virtual between-visit healthcare provider released new data demonstrating that its GLP-1 companion program significantly improves persistence rates for GLP-1 medications.
- The analysis found that members in Omada's program achieved weight loss results similar to those seen in controlled research settings, underscoring the importance of comprehensive support for individuals on these transformative medications.
- The findings provide
Read More
Nabla Raises $70M to Build an “Agentic” AI Assistant for Clinicians
What You Should Know:
- Nabla, one of the most widely adopted AI assistants in clinical care secures $70M in Series C funding led by HV Capital, with Highland Europe joining as a key investor, alongside DST Global, and existing investors Cathay Innovation, and Tony Fadell’s Build Collective. The funding brings Nabla’s total capital raised to $120M.
- The new capital will accelerate product development, fuel growth across Nabla’s technical and go-to-market teams, and support strategic
Read More
Sword Health Raises $40M, Launches AI-Powered Mental Health Solution “Mind”
What You Should Know:
- Sword Health, the world’s leading AI Care company raises $40M funding round at a $4B valuation, led by General Catalyst.
- The company also unveiled Mind, a revolutionary mental health solution that combines AI and licensed clinicians to deliver continuous, personalized care, aiming to transform mental health from episodic talk therapy to a proactive, always-on support system.
- The new funding will accelerate the evolution of Sword's AI Care model,
Read More
HOPPR Secures $31.5M to Scale its AI Medical Imaging Development Platform
What You Should Know:
- HOPPR, the company revolutionizing how AI imaging applications are built, validated, and deployed secures $31.5M in an oversubscribed Series A funding round led by Kivu and Greycroft, with participation from PSG Equity, Morningside Capital, Fortitude Ventures, and existing investor Health 2047.
- HOPPR intends to accelerate platform development, scale operations, expand its foundation model capabilities, and grow its team of top-tier talent.
Addressing a
Read More
Mount Sinai Deploys Flosonics’ Wearable Ultrasound to Optimize ICU Care
What You Should Know:
- Flosonics Medical, the leader in wearable ultrasound for critical care, today announced that The Mount Sinai Hospital has adopted FloPatch, the first wireless Doppler ultrasound device, in its surgical and transplant intensive care units.
- This milestone marks the company’s first East Coast deployment, expanding its U.S. footprint and reinforcing growing demand for real-time, individualized fluid management in ICUs.
FloPatch: Enabling Precision Fluid
Read More
Quilt Health Raises $6M to Modernize Clinical Trial Access for Complex Diseases
What You Should Know:
- Quilt Health, a digital health company dedicated to bridging gaps in treatment access for complex diseases secures $6M in seed funding round, bringing its total funding to $8M. The round was led by MaC Venture Capital and Underscore Ventures, with participation from Meridian Street Capital, BoxGroup, Watershed VC, and Coalition Operators.
- Founded with an initial focus on sickle cell disease, the company plans to use the new capital to rapidly expand into
Read More
Cleveland Clinic & Amwell Expand Virtual Cancer Concierge Program Nationwide
What You Should Know:
- The Clinic by Cleveland Clinic, a leading provider of virtual second opinions (VSOs), announced the expansion of Cancer Concierge by Cleveland Clinic—a program connecting cancer patients across the U.S. with expert oncology subspecialists.
- The program, offered by The Clinic and its partner Amwell, expands on traditional VSOs by offering advanced subspecialty reviews, insight into innovative treatments and trials, cancer education content, and optional follow-up
Read More
Xsolis GenAI Pilot at Beacon Health System Reduces Medical Necessity Review Time by 68%
What You Should Know:
- Xsolis, an AI-driven technology company announced the initial results of its new generative AI (GenAI) solution pilot, which dramatically streamlines medical necessity reviews. Beacon Health System, a not-for-profit health system, piloted the new Xsolis GenAI solution and saw a significant decrease in administrative burden, which helped optimize precious clinical resources and streamline payer interactions.
- The results from the three-month pilot
Read More
